Table 1 Clinicopathological features of 98 patients
From: Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
Age | |
Median (IQR) | 65 (59–72) |
Stage | |
FIGO 1 | 58 |
FIGO 2 | 7 |
FIGO 3 | 26 |
FIGO 4 | 8 |
Histology | |
Endometrioid | 69 |
Serous Papillary/Clear cell | 22 |
Carcinosarcoma | 8 |
Lymph nodes | |
LN negative | 76 |
LN positive | 21 |
Unknown | 2 |
Grade | |
1 | 17 |
2 | 39 |
3 | 42 |
Unknown | 1 |
Risk status | |
Low risk | 29 |
High risk | 70 |
Adjuvant treatment | |
No Adjuvant treatment | 5 |
Radiotherapy | 54 |
Chemotherapy | 19 |
Chemotherapy + radiotherapy | 20 |
Recurrence | |
None | 73 |
Local | 20 |
Distant | 6 |